Type 2 Diabetes Drug Liraglutide powder from buzai232's blog

Victoza falls under the umbrella of incretin mimetics, a class of drugs used to treat type 2 diabetes that works by boosting insulin production in the pancreas, lowering the patient’s blood sugar levels.Liraglutide powder

Victoza, which is manufactured by Novo Nordisk, was first approved for market in 2010. It quickly became one of the most popular type-2 diabetes treatments.

However, more recently Victoza has faced criticisms over its dangerous side effects, which Novo Nordisk failed to warn consumers about. As a result, a number of Victoza lawsuits have been filed against the manufacturer on behalf of individuals who were injured by Victoza.Byetta (exenatide) is a GLP-1 receptor agonist which mimics the effect of glucagon-like peptide-1, a hormone that increases insulin production when blood sugar is high. Byetta is administered as a twice-daily injection.

Bydureon is also a GLP-1 receptor agonists and contains the same main ingredient as Byetta – exenatide. Bydureon is a longer-lasting version of Byetta, requiring a once a week injection.

Rather than an injection, Januvia (sitagliptin) is a once-daily pill used to lower blood glucose levels in patients with Type 2 diabetes. Januvia helps to increase the insulin produced by the pancreas when blood sugar levels are high and help to reduce the amount of sugar produced by the liver. Also a pill, Janumet is a combination drug – it combines sitagliptin and metformin into a single pill.
Researchers have linked Victoza to a number of dangerous and potentially life-threatening side effects. These side effects were not included on the original Victoza warning label and the public has now been made aware of these side effects by researchers and through drug safety communications.

Pancreatitis and Pancreatic Cancer — Following a number of concerning reports linking Victoza to pancreatitis, the U.S. Food and Drug Administration (FDA) conducted an investigation into Victoza health risks in 2013. The FDA found that pancreatitis was more likely to occur in patients using Victoza than in patients using any other type-2 diabetes medication. As a result, the FDA mandated a black box warning making consumers aware of Victoza’s increased risk of pancreatitis. Other research and studies have shown that this form of type-2 diabetic treatment may be linked to pancreatic cancer. In a recent clinical trial, 13 patients were diagnosed with pancreatic cancer while only 5 patients taking the placebo were diagnosed with pancreatic cancer.
Thyroid Cancer — Following a number of concerning reports linking Victoza to thyroid cancer, the U.S. Food and Drug Administration (FDA) mandated a black box warning for the drug, the strongest warning a drug can carry. Researchers found an increased risk of tumors — sometimes cancerous — developing in the thyroid glands of rats and mice.
If you are taking Victoza and have developed pancreatic cancer, pancreatitis, or thyroid cancer, you should stop taking Victoza and talk to your doctor and an experienced personal injury lawyer right away.

If you had previously taken Victoza and have developed pancreatic cancer, pancreatitis, or thyroid cancer, you should contact an experienced personal injury lawyer right away.